as on November 28, 2025 at 11:29 pm IST
Day's Low
Day's High
1.03%
Downside
0.86%
Upside
52 Week's Low
52 Week's High
21.29%
Downside
25.31%
Upside
Check Biontech Se market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$24.7B
EPS (TTM)
-3.8221
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
-0.43%
PE Ratio (TTM)
-40.18
Industry PE ratio
19.200384615384614
PEG Ratio
0.0449
EBITDA
-467.8M
Revenue (TTM)
3.2B
Profit Margin
-18.13%
Return On Equity TTM
-3.04%
Track how Biontech Se P/E has moved over time to understand its valuation trends.
Biontech Se in the last 5 years
Lowest (-69.14x)
June 30, 2025
Today (-40.18x)
November 29, 2025
Industry (19.20x)
November 29, 2025
Highest (26.31x)
December 31, 2023
Today’s Price to Earnings Ratio: -40.18x
Compare market cap, revenue, PE, and other key metrics of Biontech Se with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $24.7B | -6.22% | -40.18 | -18.13% | |
| BUY | $44.3B | 422.04% | -16.34 | -264.83% | |
| BUY | $58.8B | 247.47% | 1435.87 | 1.36% | |
| BUY | $110.8B | 91.26% | 30.39 | 31.35% | |
| BUY | $83.2B | 51.77% | 18.8 | 32.13% |
The Biontech Se stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Biontech Se investment value today
Current value as on today
₹93,012
Returns
Returns from Biontech Se Stock
Dollar Returns*
₹5,876 (+5.88%)
Based on 24 analysts
54.17%
Buy
37.50%
Hold
8.33%
Sell
Based on 24 analysts, 54.17% of analysts recommend a 'BUY' rating for Biontech Se. Average target price of $136.91
Get share price movements and forecasts by analysts on Biontech Se.
What analysts predicted
24.65%UPSIDE
Target Price
$136.91
Current Price
$103.16
Analyzed by
24 Analysts
Target
$136.91
Biontech Se target price $136.91, a slight upside of 24.65% compared to current price of $103.16. According to 24 analysts rating.
Search interest for Biontech Se Stock has increased by 31% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:31% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 26 November
Thu, 03:28 AM
-BioNTech's exchange offer for CureVac shares approved, aiming for at least 80% ownership to enhance market position.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
![]()
Biontech SE has shown strong revenue growth over the last three quarters. The revenue increased from $182.8 million to $1.51 billion, resulting in an average growth rate of 56.4% per quarter.
Profit Spike
![]()
Biontech SE has shown significant improvement in its net profit over the past three quarters. The net profit has increased from -415.8 million dollars to -28.7 million dollars, marking an average increase of 627.3% each quarter. This trend indicates a strong recovery in the company's financial performance.
Price Rise
![]()
In the last 7 days, BNTX stock has moved up by 7.9%
Against Peers
![]()
In the last 3 years, Insmed Incorporated has given 1047.3% return, outperforming this stock by 1084.3%
Against Peers
![]()
In the last 1 year, Insmed Incorporated has given 176.4% return, outperforming this stock by 189.3%
| Organisation | Biontech Se |
| Headquarters | An der Goldgrube 12, Mainz, Germany, 55131 |
| Industry | Health Technology |
| CEO | Dr. Ugur Sahin M.D. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Dr. Ugur Sahin M.D. | Co-Founder, CEO & Chair of the Management Board |
Dr. Ozlem Tureci M.D. | Co-Founder, Chief Medical Officer & Member of Management Board |
Mr. Douglas Maffei Ph.D. | Vice President of Strategy & Investor Relations |
Ms. Beate Berns | Senior Vice President of Global Human Resources |
Dr. Oliver Henning Ph.D. | Senior Vice President of Operations |
Dr. Sierk Poetting Ph.D. | MD, COO & Member of Management Board |
Dr. James Timothy Patrick Ryan Ph.D. | Chief Legal & Business Officer and Member of the Management Board |
Ms. Annemarie Hanekamp | Chief Commercial Officer & Member of Management Board |
Mr. Ramon Zapata-Gomez | CFO & Member of Management Board |
Ms. Lisa Birringer | Senior Vice President of Global Financial Reporting & Accounting |
Biontech Se share price today is $103.16 as on at the close of the market. Biontech Se share today touched a day high of $104.05 and a low of $102.1.
Biontech Se share touched a 52 week high of $129.27 on and a 52 week low of $81.2 on . Biontech Se stock price today i.e. is closed at $103.16,which is 20.20% down from its 52 week high and 27.04% up from its 52 week low.
Biontech Se market capitalisation is $0.02T as on .
Indian investors can start investing in Biontech Se (BNTX) shares with as little as ₹89.436 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹894.36 in Biontech Se stock (as per the Rupee-Dollar exchange rate as on ).
Based on Biontech Se share’s latest price of $103.16 as on November 28, 2025 at 11:29 pm IST, you will get 0.0969 shares of Biontech Se. Learn more about
fractional shares .
Biontech Se stock has given -6.22% share price returns and 20.48% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?